P3LAB

P3Lab is a European MedTech company that develops NeuroClues, a portable eye-tracking medical device and platform that records and analyzes eye movements to provide objective, quantified biomarkers for the earlier detection of neurological disorders including Parkinson's disease, Alzheimer's disease, and multiple sclerosis. Founded in 2020 by Antoine Pouppez, Pierre Daye, and Pierre Pouget — former ICM and IBA researchers — the company's CE-marked platform delivers clinically validated assessments in minutes at the point of care, enabling neurologists to identify disease years before visible symptoms appear. In April 2026, the company raised a EUR 10M Series A to accelerate rollout across Europe and prepare for U.S. market entry.